HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 2149-2158

  Quintana, Francisco J ^a   Gerber, Doron ^a   Kent, Sally C ^b   Cohen, Irun R ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 41; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE RECEPTOR;

ADJUVANT ARTHRITIS; AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; INHIBITION KINETICS; PRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; VIRUS CELL INTERACTION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD4; ARTHRITIS, EXPERIMENTAL; CARCINOGENS; CELL LINE; CELL PROLIFERATION; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IONOMYCIN; IONOPHORES; LYMPHOCYTE ACTIVATION; MEMBRANE FUSION; PEPTIDES; RATS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 23644459494     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23956     Document Type: Article

References (57)

1. Douek, D.C., Picker, L.J., and Koup, R.A. 2003. T cell dynamics in HIV-1 infection. Annu. Rev. Immunol. 21:265-304.
2. Letvin, N.L., and Walker, B.D. 2003. Immunopathogenesis and immunotherapy in AIDS virus infections. Nat. Med. 9:861-866.
3. Stevenson, M. 2003. HIV-1 pathogenesis. Nat. Med. 9:853-860.
4. Johnson, W.E., and Desrosiers, R.C. 2002. Viral persistance: HIV's strategies of immune system evasion [review]. Annu. Rev. Med. 53:499-518.
5. Grossman, Z., Meier-Schellersheim, M., Sousa, A.E., Victorino, R.M., and Paul, W.E. 2002. CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8:319-323.
6. Morris, P.J., and Rosenberg, E.S. 2001. Cellular immune response to human immunodeficiency virus. AIDS. 15:16-21.
7. Altfeld, M., and Rosenberg, E.S. 2000. The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1. Curr. Opin. Immunol. 12:375-380.
8. Wyatt, R., and Sodroski, J. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens [review]. Science. 280:1884-1888.
9. Kliger, Y., et al. 1997. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study. J. Biol. Chem. 272:13496-13505.
10. Peisajovich, S.G., and Shai, Y. 2003. Viral fusion proteins: multiple regions contribute to membrane fusion [review]. Biochim. Biophys. Acta. 1614:122-129.
11. Suarez, T., Nir, S., Goni, P.M., Saez-Cirion, A., and Nieva, J.L. 2000. The pre-transmembrane region of the human immunodeficiency virus type-1 glycoprotein: a novel fusogenic sequence. FEBS Lett. 477:145-149.
12. Chan, D.C., Fass, D., Berger, J.M., and Kim, P.S. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:263-273.
13. Lawless, M.K., et al. 1996. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry. 35:13697-13708.
14. Cladera, J., Martin, I., and O'Shea, P. 2001. The fusion domain of HIV gp41 interacts specifically wich heparan sulfate on the T-lymphocyte cell surface. EMBO J. 20:19-26.
15. Gerber, D., et al. 2004. Inhibition of HIV-1 glycoprotein-mediated cell fusion by a D,L-amino acid-containing fusion peptide: possible recognition of the fusion complex. J Biol. Chem. 279:48224-48230.
16. Davts, D.M., and Dustin, M.L. 2004. What is the importance of the immunological synapse [review]? Trends Immunol. 25:323-327.
17. Huppa, J.B., Gleimer, M., Sumen, C., and Davis, M.M. 2003. Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 4:749-755.
18. Huppa, J.B., and Davis, M.M. 2003. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3:973-983.
19. Heidecker, M., Yan-Marriott, Y., and Marriott, G. 1995. Proximity relationships and structural dynamics of the phalloidin binding site of actin filaments in solution and on single actin filaments on heavy meromyosin. Biochemistry. 34:11017-11025.
20. Quintana, F.J., Carmi, P., Mor, F., and Cohen, I.R. 2003. DNA fragments of the human 60-kDa heat shock protein (HSP60) vaccinate against adjuvant arthritis: identification of a regulatory HSP60 peptide. J. Immunol. 171:3533-3541.
21. Quintana, F.J., Carmi, P., Mor, F., and Cohen, I.R. 2002. Inhibition of adjuvant: arthritis by a DNA vaccine encoding human heat shock protein 60. J. Immunol. 169:3422-3428.
22. Ota, K., et al. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
23. Wang, X.M., et al. 2002. T-cell antigen receptor peptides inhibit: signal transduction within the membrane bilayer. Clin. Immunol. 105:199-207.
24. Manolios, N., et al. 1997. T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat. Med. 3:84-88.
25. Ballmer-Hofer, K., Schlup, V., Burn, P., and Burger, M.M. 1982. Isolation of in situ crosslinked ligand-receptor complexes using an anticrosslinker specific antibody. Anal. Biochem. 126:246-250.
26. Gerber, D., and Shai, Y. 2000. Insertion and organization within membranes of the delta-endotoxin pore-forming domain, helix 4-loop-helix 5, and inhibition of its activity by a mutant helix 4 peptide. J. Biol. Chem. 275:23602-23607.
27. Holoshitz, J., Matiriau, A., and Cohen, I.R. 1984. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. Clin. Invest. 73:211-215.
28. Holoshitz, J., Naparstek, Y., Ben-Nun, A., and Cohen, I.R. 1983. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 219:56-58.
29. Anderton, S.M., van der Zee, R., Noordzij, A., and van Eden, W. 1994. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J. Immunol. 152:3656-3664.
30. van Eden, W., et al. 1985. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc. Natl. Acad. Sci. U. S. A. 82:5117-5120,
31. Tanaka, S., et al. 1999. Activation of T cells recognizing an epitope of heat-shock protein 70 can protect against rat adjuvant arthritis. J. Immunol. 163:5560-5565.
32. Ruegg, C.L., Monell, C.R., and Strand, M. 1989. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:3257-3260.
33. Ruegg, C.L., Monell, C.R., and Strand, M. 1989. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types 1 and II. J. Virol. 63:3250-3256.
34. Ruegg, C.L., and Strand, M. 1991. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cell Immunol. 137:1-13.
35. Ruegg, C.L., and Strand, M. 1990. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J. Immunol. 144:3928-3935.
36. Moteno, M.R., Pascual, R., and Villalain, J. 2004. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan. Biochim. Biophys. Acta. 1661:97-105.
37. Peisajovich, S.G., and Shai, Y. 2002. New insights into the mechanism of virus-induced membrane fusion. Trends Biochem. Sci. 27:183-190.
38. Parren, P.W., Burton, D.R., and Sattentau, Q.J. 1997. HIV-1 antibody-debris or virion? Nat. Med. 3:366-367.
39. Tas, M., Drexhage, H.A., and Goudsmit, J. 1988. A monocyte chemotaxis inhibiting factor in serum of HIV infected men shares epitopes with the HIV transmembrane protein gp41. Clin. Exp. Immunol. 71:13-18.
40. van Kooyk, Y., and Geijtenbeek, T.B. 2003. DC-SIGN: escape mechanism for pathogens [review]. Nat. Rev. Immunol. 3:697-709.
41. Geijtenbeek, T.B., et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding prorein that enhances trans-infection of T cells. Cell 100:587-597.
42. Kwon, D.S., Gregorio, G., Bitton, N., Hendrickson, W.A. and Littman, D.R. 2002. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity. 16:135-144.
43. Pope, M., et al. 1994. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 78:389-398.
44. Sugaya, M., Lore, K., Koup, R.A., Douek, D.C., and Blauvelt, A. 2004. HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J. Immunol. 172:2219-2224.
45. McDonald, D., et al. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science. 300:1295-1297.
46. Matsue, H., et al. 1999. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J. Immunol 162:5287-5298.
47. Woods, T.C., Roberts, B.D., Butera, S.T., and Folks, T.M. 1997. Loss of inducible virus in CD45RA naive cells after human immunodeficiency virus-1 entry accounts for preferential vital replication in CD45R memory cells. Blood. 89:1635-1641.
48. Douek, D.C., et al. 2002. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 417:95-98.
49. Desrosiers, R.C. 1999. Strategies used by human immunodeficiency virus that allow persistent viral replication. Nat. Med. 5:723-725.
50. Karlsson, G.B., et al. 1998. The envelope glycoptotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J. Exp. Med. 188:1159-1171.
51. Reizis, B., et al. 1996. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI. Int. Immunol. 8:1825-1832.
52. Merrifield, R.B., Vizioli, L.D., and Boman, H.G. 1982. Synthesis of the antibacterial peptide cecropin A (1-33). Biochemistry. 21:5020-5031.
53. van Eden, W., et al. 1988. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 331:171-173.
54. Mycko, M.P., et al. 2004. Cross-reactive TCR responses to self antigens presented by different MHC class II molecules. J. Immunol. 173:1689-1698.
55. Kaleeba, J.A., Offnet, H., Vandenbatk, A.A., Lublinski, A., and Weinberg, A.D. 1998. The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells. Int. Immunol. 10:453-461.
56. Viglietta, V., Kent, S.C., Orban, T., and Hafler, D.A. 2002. GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes. J. Clin. Invest. 109:895-903. doi:10.1172/JCI200214114.
57. Adachi, T., et al. 1996. The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J. 15:1534-1541.